Streetbeat News

ACB

Aurora Cannabis Inc.

https://www.auroramj.com

Industry

Drug Manufacturers - Specialty & Generic

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Open

5.09

Mkt cap

278M

Volume

1.4M

High

5.24

P/E Ratio

-11.31

52-wk high

9.35

Low

5.05

Div yield

N/A

52-wk low

2.84

The report by Zuanic & Associates on the Canadian cannabis market shows regional disparities and growth trends, with a 16% YoY growth in nationwide sales. Alberta leads in store density and per capita spending, while Quebec has the lowest. The market is affected by high excise taxes, product caps, and marketing restrictions. Organigram, Village Farms International, Cronos, and others saw varying growth rates across provinces, while companies like Canopy and Tilray experienced declines. The upcoming Vape Market Trends panel will feature CEOs from TILT Holdings and Greenlane Holdings.

Portfolio Pulse from Nicolás Jose Rodriguez

December 08, 2023 | 1:52 pm

Republican Representative David Joyce is set to introduce the STATES 2.0 Act, which aims to de-schedule state-legal cannabis at the federal level. This legislative move could significantly impact the legal landscape for cannabis businesses in the United States.

Portfolio Pulse from Benzinga Newsdesk

December 06, 2023 | 7:46 pm

Tilray Brands CEO Irwin Simon visited Israel to meet business partners and traveled to Germany in anticipation of cannabis legalization. Tilray (NASDAQ:TLRY) is well-positioned to benefit from potential German legalization, with its European headquarters in Germany. Aurora Cannabis (NASDAQ:ACB) is also among the companies likely to benefit. Despite a delay in the German legalization vote, Tilray shares rose 8.42% and an additional 0.24% after hours on Monday.

Portfolio Pulse from Nina Zdinjak

December 05, 2023 | 3:43 pm

The article lists the cannabis stocks that experienced significant gains and losses on December 4, 2023. Notable gainers include Global Compliance, Indiva, and Canopy Growth, with increases of 89.29%, 38.93%, and 22.59% respectively. On the losing side, Global Hemp Group led the declines with a 76.68% drop. The article reflects the volatility in the cannabis market and may influence investor sentiment.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 9:30 pm

German lawmakers are preparing to vote on a marijuana legalization measure, with the Health Minister optimistic about its implementation next year. The measure includes provisions for recreational use, cultivation, and social clubs. However, the Bundesrat, particularly Bavaria, may challenge the reform. U.S. and Canadian cannabis companies like Tilray Brands Inc., Aurora Cannabis Inc., and Curaleaf Holdings, Inc. are well-positioned to capitalize on the German market. CBD of Denver Inc. is expanding in Europe with plans for Cannabis Clubs in Germany. Organigram Holdings Inc. has a supply agreement with Sanity Group GmbH, which also received investment from British American Tobacco and Snoop Dogg's Casa Verde Capital. Cantourage, a Berlin startup, is the first medical cannabis company listed on the Frankfurt stock exchange.

Portfolio Pulse from Jelena Martinovic

December 01, 2023 | 6:35 pm

Israel's cannabis industry is growing, with increased medical cannabis prescriptions post-Gaza war. ICD Pharma, Tikun Olam Cannbit (TKUNF), and Syqe Medical are key players, with Syqe set for a $650 million acquisition by Philip Morris. IM Cannabis Corp. (IMCC) was the first Israeli cannabis company on NASDAQ. Curaleaf Holdings (CURLF) and Aurora Cannabis (ACB) are North American companies involved in Israel's market. SciSparc Ltd. (SPRC) plans to merge with an unnamed vehicle importer, expecting the importer to hold 80% of the combined entity post-merger and financing round.

Portfolio Pulse from Jelena Martinovic

November 22, 2023 | 3:18 pm

On November 20, 2023, several marijuana stocks experienced significant price movements. Notable gainers included 1933 Industries, Heritage Cannabis Holding, and Global Hemp Group, with shares rising by 50.69%, 35.74%, and 24.03% respectively. Neptune Wellness Solutions, Corbus Pharmaceuticals, Canopy Growth, and Aurora Cannabis were among the gainers on NASDAQ. Conversely, Craftport Cannabis, GrowLife, and EVIO were the biggest losers, with their shares plummeting by over 99%. Other notable losers included Body and Mind, Leafbuyer Technologies, and Cresco Labs.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 9:30 pm

Senate Majority Leader Chuck Schumer stated that the Senate is close to a floor vote on the SAFER Banking Act, which aims to reform marijuana banking laws. The bill requires more GOP support to reach the 60-vote threshold for passage. Schumer emphasized the public's support for marijuana legalization and the need to rectify harms caused by the drug war, particularly in minority communities. The bill includes provisions to support small minority businesses and may be further amended to address cannabis expungements and gun rights for consumers. Schumer has not personally used marijuana but supports legalization. Former NBA star Al Harrington, owner of cannabis company Viola, participated in the interview.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 4:52 pm

Willow Biosciences Inc. (OTCQB:CANSF) reported strong financial results for Q3 2023, with record revenue of $0.7 million and year-to-date revenue of $1.1 million. The company, specializing in precision fermentation for health and wellness, food and beverage, and personal care markets, has made significant strides in business expansion and operational efficiency. Key achievements include a reduction in cash burn, a successful insider-led convertible debenture financing, and progress in various R&D programs. Willow also settled patent litigation with Aurora Cannabis Inc. (NASDAQ:ACB). Shares of CANSF rose 8.13% to $0.0556.

Portfolio Pulse from Joana Scopel

November 15, 2023 | 9:45 pm

Republican presidential candidate Vivek Ramaswamy plans to remove federal restrictions on marijuana and psychedelics for veterans with PTSD if elected. He supports descheduling certain substances and has criticized federal prohibition on marijuana. Despite this, he voted against Ohio's state-level legalization due to conflicts with federal law and concerns over federal power overreach. His stance has been seen as inconsistent, especially with his proposal to expand the DEA while reducing other federal agencies.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 6:26 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.